Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
- Conditions
- Cerebral Amyloid AngiopathyIntracerebral Hemorrhage Lobar
- Interventions
- Drug: Matching placebo
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT07026994
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
🇨🇳West China Hospital, Sichuan University, Chengdu, China
🇨🇳Huashan Hospital, Fudan University, Shanghai, China
CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: 0.25mg/kg TNKDrug: Standard medical treatment
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 890
- Registration Number
- NCT06994975
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, China
Early Diagnosis and Recurrence Monitoring of Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 1200
- Registration Number
- NCT06991452
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
- Conditions
- Hyperuricemia or GoutNephrolithiasis
- Interventions
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 312
- Registration Number
- NCT06966635
- Locations
- 🇨🇳
Huashan hospital, Fudan university, Shanghai, China
Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms
- Conditions
- Flow Diverter
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 523
- Registration Number
- NCT06943729
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: Pegylated Interferon-alpha (IFN)
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06923280
- Locations
- 🇨🇳
Huashan Hospita, Shanghai, China
Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige Syndrome
- Conditions
- Meige Syndrome
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06912282
- Locations
- 🇨🇳
Huashan Hospital, Fudan University., Shanghai, Shanghai, China
Research of Brachial Plexus Anatomy
- Conditions
- Brachial Plexus InjuryUltrasound
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06901063
- Locations
- 🇨🇳
Huashan Hospital Fudan University, Shanghai, Shanghai, China
Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: PegIFN alfa-2bDrug: PegIFN alfa-2b and NUC
- First Posted Date
- 2025-03-28
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 360
- Registration Number
- NCT06900166
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients with Severe Consciousness Disorders
- Conditions
- Disorder of ConsciousnessTemporal Interference Stimulation
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06896279
- Locations
- 🇨🇳
Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, Shanghai, China